开发和验证可解释的合规预测器来预测败血症死亡风险:回顾性队列研究
Meicheng Yang1, Hui Chen2, Wenhan Hu2
1State Key Laboratory of Digital Medical Engineering, School of Instrument Science and Engineering, Southeast University, Nanjing, China.
Journal of medical Internet research
|March 18, 2024
概括
这项研究开发了一种可解释的人工智能 (AI) 模型,用于预测重症患者的败血症死亡风险. 通过符合性预测增强的人工智能模型,通过提供可靠的风险评估和信心水平来改善临床决策.
科学领域:
- 关键护理医学 关键护理医学
- 医疗保健中的人工智能
- 生物医学信息学 生物医学信息学
背景情况:
- 早期识别高风险败血症患者对于改善结果至关重要.
- 在临床实践中采用人工智能的障碍包括缺乏解释性,概括性问题和自动化偏见.
研究的目的:
- 开发和验证人工智能辅助的合规预测器,用于严重病患者的败血症死亡风险.
- 提高人工智能模型的解释性,并为预测提供信心水平.
主要方法:
- 从Beth Israel Deaconess医疗中心和飞利浦eICU研究院数据库中提取回顾性数据.
- 开发一个梯度增强机器AI模型用于败血症死亡率预测.
- 蒙德里安对不确定性预测的应用和沙普利对模型可解释性的附加解释.
主要成果:
- 人工智能模型实现了内部AUC为0.858,外部AUC为0.800.
- 符合性预测减少了预测错误,并为临床医生审查标记了不确定的病例,超过了标准AI预测.
- 关键预测因素包括急性生理学得分III,年龄,尿量,血管压缩剂和肺部感染.
结论:
- 将AI模型解释与符合性预测相结合,有助于更好的临床决策.
- 这种方法增强了人工智能系统的转化为治疗败血症的医疗实践.
相关概念视频
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Assumptions of Survival Analysis
126
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126
Kaplan-Meier Approach
136
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
136
Censoring Survival Data
88
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
88
Comparing the Survival Analysis of Two or More Groups
183
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
183
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


